Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1997 Jan-Mar;3(1):33–39. doi: 10.3201/eid0301.970104

Fluoroquinolone resistance in Neisseria gonorrhoeae.

J S Knapp 1, K K Fox 1, D L Trees 1, W L Whittington 1
PMCID: PMC2627594  PMID: 9126442

Abstract

Fluoroquinolones and broad-spectrum cephalosporins are the most effective antimicrobial agents for the treatment of gonorrhea. However, clinically significant resistance to fluoroquinolones has emerged in Neisseria gonorrhoeae. Fluoroquinolone-resistant strains account for approximately 10% of all gonococcal strains in Hong Kong and the Republic of the Philippines. As many as 50% of strains from some Far Eastern countries exhibit decreased susceptibility (intermediate resistance) to fluoroquinolones. Strains with intermediate resistance and clinically significant resistance are being isolated sporadically in North America, where resistant strains have been associated with an outbreak and with failure of infections to respond to treatment with doses of ciprofloxacin and ofloxacin recommended by the Centers for Disease Control and Prevention; strains exhibiting decreased susceptibility to these agents are endemic in at least one metropolitan area. Monitoring for fluoroquinolone resistance is now critical for ensuring adequate treatment of infections with resistant strains and for maximizing the time during which fluoroquinolones may be used to treat gonorrhea.

Full Text

The Full Text of this article is available as a PDF (43.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeyewickereme I., Senaratne L., Prithiviraj V. B. Rapid emergence of 4-fluroquinolone resistance with associated decline in penicillinase-producing Neisseria gonorrhoeae in Colombo, Sri Lanka. Genitourin Med. 1996 Aug;72(4):302–302. doi: 10.1136/sti.72.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Belland R. J., Morrison S. G., Ison C., Huang W. M. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol. 1994 Oct;14(2):371–380. doi: 10.1111/j.1365-2958.1994.tb01297.x. [DOI] [PubMed] [Google Scholar]
  3. Birley H., McDonald P., Carey P., Fletcher J. High level ciprofloxacin resistance in Neisseria gonorrhoeae. Genitourin Med. 1994 Aug;70(4):292–293. doi: 10.1136/sti.70.4.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Centers for Disease Control and Prevention (CDC) Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995. MMWR Morb Mortal Wkly Rep. 1995 Oct 20;44(41):761–764. [PubMed] [Google Scholar]
  5. Clendennen T. E., Echeverria P., Saengeur S., Kees E. S., Boslego J. W., Wignall F. S. Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrob Agents Chemother. 1992 Aug;36(8):1682–1687. doi: 10.1128/aac.36.8.1682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Corkill J. E., Percival A., Lind M. Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains. J Antimicrob Chemother. 1991 Oct;28(4):601–604. doi: 10.1093/jac/28.4.601. [DOI] [PubMed] [Google Scholar]
  7. Deguchi T., Yasuda M., Asano M., Tada K., Iwata H., Komeda H., Ezaki T., Saito I., Kawada Y. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1995 Feb;39(2):561–563. doi: 10.1128/aac.39.2.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Deguchi T., Yasuda M., Nakano M., Ozeki S., Ezaki T., Saito I., Kawada Y. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother. 1996 Apr;40(4):1020–1023. doi: 10.1128/aac.40.4.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Deguchi T., Yasuda M., Nakano M., Ozeki S., Kanematsu E., Kawada Y., Ezaki T., Saito I. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1996 Oct;40(10):2437–2438. doi: 10.1128/aac.40.10.2437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gordon S. M., Carlyn C. J., Doyle L. J., Knapp C. C., Longworth D. L., Hall G. S., Washington J. A. The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. Ann Intern Med. 1996 Sep 15;125(6):465–470. doi: 10.7326/0003-4819-125-6-199609150-00006. [DOI] [PubMed] [Google Scholar]
  11. Gransden W. R., Warren C. A., Phillips I., Hodges M., Barlow D. Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet. 1990 Jan 6;335(8680):51–51. doi: 10.1016/0140-6736(90)90177-7. [DOI] [PubMed] [Google Scholar]
  12. Gransden W. R., Warren C., Phillips I. 4-Quinolone-resistant Neisseria gonorrhoeae in the United Kingdom. J Med Microbiol. 1991 Jan;34(1):23–27. doi: 10.1099/00222615-34-1-23. [DOI] [PubMed] [Google Scholar]
  13. Jaffe H. W., Schroeter A. L., Reynolds G. H., Zaidi A. A., Martin J. E., Jr, Thayer J. D. Pharmacokinetic determinants of penicillin cure of gonococcal urethritis. Antimicrob Agents Chemother. 1979 Apr;15(4):587–591. doi: 10.1128/aac.15.4.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jephcott A. E., Turner A. Ciprofloxacin resistance in gonococci. Lancet. 1990 Jan 20;335(8682):165–165. doi: 10.1016/0140-6736(90)90035-4. [DOI] [PubMed] [Google Scholar]
  15. Kam K. M., Lo K. K., Lai C. F., Lee Y. S., Chan C. B. Ofloxacin susceptibilities of 5,667 Neisseria gonorrhoeae strains isolated in Hong Kong. Antimicrob Agents Chemother. 1993 Sep;37(9):2007–2008. doi: 10.1128/aac.37.9.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kam K. M., Wong P. W., Cheung M. M., Ho N. K. Detection of quinolone-resistant Neisseria gonorrhoeae. J Clin Microbiol. 1996 Jun;34(6):1462–1464. doi: 10.1128/jcm.34.6.1462-1464.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Knapp J. S., Hale J. A., Neal S. W., Wintersheid K., Rice R. J., Whittington W. L. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob Agents Chemother. 1995 Nov;39(11):2442–2445. doi: 10.1128/aac.39.11.2442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Knapp J. S., Holmes K. K., Bonin P., Hook E. W., 3rd Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex Transm Dis. 1987 Jan-Mar;14(1):26–32. [PubMed] [Google Scholar]
  19. Knapp J. S., Mesola V. P., Neal S. W., Wi T. E., Tuazon C., Manalastas R., Perine P. L., Whittington W. L. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines. Sex Transm Dis. 1997 Jan;24(1):2–7. doi: 10.1097/00007435-199701000-00002. [DOI] [PubMed] [Google Scholar]
  20. Knapp J. S., Ohye R., Neal S. W., Parekh M. C., Higa H., Rice R. J. Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii. Antimicrob Agents Chemother. 1994 Sep;38(9):2200–2203. doi: 10.1128/aac.38.9.2200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Knapp J. S., Washington J. A., Doyle L. J., Neal S. W., Parekh M. C., Rice R. J. Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob Agents Chemother. 1994 Sep;38(9):2194–2196. doi: 10.1128/aac.38.9.2194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Putnam S. D., Lavin B. S., Stone J. R., Oldfield E. C., 3rd, Hooper D. G. Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from the United States and Southeast Asia. J Clin Microbiol. 1992 Apr;30(4):974–980. doi: 10.1128/jcm.30.4.974-980.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ringuette L., Trudeau T., Turcotte P., Yeung K., Rémis R., Perron L., Le Corre I. Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin--Quebec, 1994-1995. Can Commun Dis Rep. 1996 Aug 1;22(15):121–125. [PubMed] [Google Scholar]
  24. Schwarcz S. K., Zenilman J. M., Schnell D., Knapp J. S., Hook E. W., 3rd, Thompson S., Judson F. N., Holmes K. K. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA. 1990 Sep 19;264(11):1413–1417. [PubMed] [Google Scholar]
  25. Short H. B., Ploscowe V. B., Weiss J. A., Young F. E. Rapid method for auxotyping multiple strains of Neisseria gonorrhoeae. J Clin Microbiol. 1977 Sep;6(3):244–248. doi: 10.1128/jcm.6.3.244-248.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stein D. C., Danaher R. J., Cook T. M. Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1991 Apr;35(4):622–626. doi: 10.1128/aac.35.4.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tanaka M., Matsumoto T., Kobayashi I., Uchino U., Kumazawa J. Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan. Antimicrob Agents Chemother. 1995 Oct;39(10):2367–2370. doi: 10.1128/aac.39.10.2367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tapsall J. W., Phillips E. A., Shultz T. R., Thacker C. Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia, 1991 to 1995. Sex Transm Dis. 1996 Sep-Oct;23(5):425–428. doi: 10.1097/00007435-199609000-00014. [DOI] [PubMed] [Google Scholar]
  29. Tapsall J. W., Shultz T. R., Lovett R., Munro R. Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea. Med J Aust. 1992 Jan 20;156(2):143–143. doi: 10.5694/j.1326-5377.1992.tb126457.x. [DOI] [PubMed] [Google Scholar]
  30. Tapsall J. W., Shultz T. R., Phillips E. A. Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibiotics. Pathology. 1992 Jan;24(1):27–31. doi: 10.3109/00313029209063616. [DOI] [PubMed] [Google Scholar]
  31. Turner A., Jephcott A. E., Gough K. R. Laboratory detection of ciprofloxacin resistant Neisseria gonorrhoeae. J Clin Pathol. 1991 Feb;44(2):169–170. doi: 10.1136/jcp.44.2.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yeung K. H., Ng L. K., Dillon J. A. Evaluation of Etest for testing antimicrobial susceptibilities of Neisseria gonorrhoeae isolates with different growth media. J Clin Microbiol. 1993 Nov;31(11):3053–3055. doi: 10.1128/jcm.31.11.3053-3055.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES